Search:

Login | Subscribe

Home > Companies > Ransom(William) & Son

Price	Market	Sector	Market Cap
7.75p (0.00p) 0.00%	AIM	Medicine and Biotech Research	£6.54m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
AZH	p
BBI	p
CEN	p
CBF	2.25p	0.00%
COT	93.00p	0.54%
CRX	2.75p	0.00%
CYX	p
LAC	p
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	29.00p	7.41%
GMX	1.75p	0.00%
GNI	p
GWP	30.00p	3.45%
HML	0.42p	0.00%
MLR	p
MMG	7.25p	0.00%
MPM	14.25p	0.00%

Commentary

Natural healthcare

Recent Articles

William picks up Muscle man	01/04/2008
William Ransom	15/06/2007
William Ransom	16/11/2006
Company Watch News	11/07/2006
Ringing the changes at Monstermob	16/06/2006
William Ransom	14/06/2006
Company Watch News	08/12/2005
William Ransom	24/11/2005
Natural growth formula boosts William Ransom	01/05/2005
William Ransom & Son	15/11/2004
More

Recent Announcements

Notice of Requisition of a General Meeting	01/12/2008
Accounts For The Year Ended 31st March 2008	30/10/2008
Board Change	24/10/2008
Trading Statement	12/09/2008
Disposal of Pavacol-D	19/08/2008
Company No Longer Subject To	12/08/2008
Offer Talks Terminated	11/08/2008
Termination of Talks	06/08/2008
Termination of Distribution A	05/08/2008
EPT Disclosure	27/06/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	31/03/2006
Currency	GBP
Turnover	32.51
Operating Profit	1.96
Pretax Profit	1.53
Earnings After Tax	0.75
Profit Available For Dividend	0.00
Ordinary Dividends	0.00
Retained Profit	0.75
Shareholders Funds	37.15
Net Current Assets	7.28
Adjusted Earnings Per Share Undiluted	1.03
Adj Earnings Per Share	1.03
Dividend Per Share	1.60

Chart

Click here for interactive charting

Company Details
Address	Alexander House, 40a Wilbury Way, Hitchin, SG4 0AP
Telephone	01462 437 615
Fax	01462 420 528
Executives
Chairman	David Suddens (0.02% holding)
Chief Executive	Ivor Harrison (0.00% holding)
Finance Director	Ian Miscampbell (0.20% holding)
Non-Exec Director	Tim Bridge (0.00% holding)
Main Shareholders
	Morley Fund Management: 15.1% Resolution Asset Management: 4.2% Tim Dye: 4.1% Schroder Investment Management: 4.1%
Advisers
Nominated Adviser	Numis
Nominated Broker	Numis
Solicitors	Travers Smith Braithwaite
Auditors	Ernst & Young
Registrar	Capita Registrars

Commentary
Natural healthcare
Company Data
Code	RNSM
Sedol	GB00072496
Shares In Issue	84.435 m
Indices	Aim
Entry on AIM	21/07/2003
Interim Results	Dec
Final Results	Jun
Year End	Mar
Accounts Due	Sep
Int div payment	n/a
Fin div payment	Oct
Int net div per share	1.10
Fin net div per share	nil
Probable CGT relief	Yes